3D Cell Culture Market - Key Industry Insights, Current and Future Perspectives
What This Report Will Provide:
Downstream Processing Market: Forthcoming Trends to Boost the Global Industry Revenue
What This Report Will Provide: This study involved four major activities in estimating the current size of the downstream processing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
Biosimulation: Use of Biosimulation Solution for Pediatric Drug Development
Factors such as increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the market.
NGS-Based RNA-Sequencing: Industry is Expanding at 20% With Rapid Growth in Precision Medicine
NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.
Downstream Processing Industry is Expanding at 16.4% With Increasing Demand for Biopharmaceuticals
Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization). Market Growth and Revenue Estimation:1. Increasing Demand for Biopharmaceuticals 2. Increasing R&D Expenditure in Biopharmaceutical Companies
Epigenetics: Emergence of New Applications and Technologies Driving Industry at 13.3%
The growth in epigenetics market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the market in the coming years.
PDX Models Market: Rising Demand for Humanized PDX Models
The growth of the overall Patient Derived Xenograft Models Market can be attributed to the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. In the coming years, North America is expected to account for the largest share of the global market.
NGS-Based RNA-Sequencing Market Growing at CAGR of 20% With Rapid Growth in Precision Medicine
NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.
PDX Models Market | Growing at a CAGR of 16.7% | Growing Demand for Personalized Medicine
The growth of the overall Patient Derived Xenograft Models Market can be attributed to the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. In the coming years, North America is expected to account for the largest share of the global market.
Oligonucleotide Synthesis Market - Global Market Size Estimation and Regional Growth Analysis
Oligonucleotide synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.